The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease

Objectıve To investigate the effect of percutaneous posterior tibial nerve stimulation (PTNS) treatment after 12 weeks on urodynamic and clinical findings in patients with Parkinson's disease (PD) with neurogenic detrusor overactivity. Methods A total of 47 patients with PD with neurogenic detr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urology (Ridgewood, N.J.) N.J.), 2016-01, Vol.87, p.76-81
Hauptverfasser: Kabay, Sahin, Canbaz Kabay, Sibel, Cetiner, Mustafa, Mestan, Emine, Sevim, Mehmet, Ayas, Selahattin, Ozden, Hilmi, Ozisik Karaman, Handan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 81
container_issue
container_start_page 76
container_title Urology (Ridgewood, N.J.)
container_volume 87
creator Kabay, Sahin
Canbaz Kabay, Sibel
Cetiner, Mustafa
Mestan, Emine
Sevim, Mehmet
Ayas, Selahattin
Ozden, Hilmi
Ozisik Karaman, Handan
description Objectıve To investigate the effect of percutaneous posterior tibial nerve stimulation (PTNS) treatment after 12 weeks on urodynamic and clinical findings in patients with Parkinson's disease (PD) with neurogenic detrusor overactivity. Methods A total of 47 patients with PD with neurogenic detrusor overactivity were enrolled in the study. Urodynamic studies before and after 12-week PTNS treatment were performed. International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), Overactive Bladder Questionnaire (OAB-V8), and Overactive Bladder Questionnaire Short Form (OAB-q SF) have been assessed before and after PTNS treatment. Results The mean first involuntary detrusor contraction volume ( 1st IDCV) on standard cystometry was 133.2 ± 48.1 (24-265) mL, whereas it was 237.3 ± 43.1 (145-390) mL after PTNS. The mean maximum cystometric capacity (MCC) on standard cystometry was 202.2 ± 36.5 (115-320) mL, whereas it was 292.1 ± 50.6 (195-395) mL after stimulation. The improvements in the first involuntary detrusor contraction volume and maximum cystometric capacity were statistically significant after stimulation. The mean Pdetmax at first involuntary detrusor contraction, maximal detrusor pressure at maximum cystometric capacity, PdetQmax, Qmax, and post-void residual volume were statistically significant after 12-week stimulation. Mean parametric improvements at 12-week PTNS treatment from baseline included daytime frequency decreased by 5.6 voids daily, urge incontinence decreased by 3.1 episodes daily, urgency episodes decreased by 6.3 episodes daily, nocturia decreased by 2.7 voids, and voided volume improved by a mean of 92.6 mL. The change from baseline on the ICIQ-SF, OABv8, and OAB-q at 12-week PTNS treatment demonstrated statistically significant improvements. Conclusion These results have demonstrated that PTNS improves the lower urinary tract symptoms and urodynamic parameters in patients with PD.
doi_str_mv 10.1016/j.urology.2015.09.026
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1762348221</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0090429515009279</els_id><sourcerecordid>1762348221</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-f929ffdc5ffce07177a554f837140675ab27719f354bf91211751800d0efa5ce3</originalsourceid><addsrcrecordid>eNqFUs1uEzEQthCIhsAjgHyDSxbbu17HF1CV8idVbURTcbQc77h1umsX2xtpn4ZXxVECBy5IlmxL38_MfIPQa0oqSmj7fleNMfThbqoYobwisiKsfYJmlDOxkFLyp2hGiCSLhkl-hl6ktCOEtG0rnqMz1jZ1y2g9Q78294BXvfPO6B5r3-HbGLrJ68EZ_B3S2OeEg8VriGbM2kMYE16HlCG6EPHGbV3hXUHcA77Jbhh7nV3wuJwrKBXeQVHGF5DjmAr-eg9Rm-z2Lk_YebwuaPDF4ofL9-UXH5xPwb9N-MIl0AleomdW9wlene45uv38abP6uri8_vJtdX65MA0jeWElk9Z2hltrgAgqhOa8scta0Ia0gustE4JKW_NmayVllApOl4R0BKzmBuo5enfUfYzh5wgpq8ElA31_bFlR0bK6WbIytDniR6iJIaUIVj1GN-g4KUrUIRu1U6ds1CEbRaQq2RTem5PFuB2g-8v6E0YBfDwCoDS6dxBVMmU6BjoXwWTVBfdfiw__KJhTtA8wQdqFMfoyRUVVYoqom8OCHPaD8vJiQta_AYbLuyU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1762348221</pqid></control><display><type>article</type><title>The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Kabay, Sahin ; Canbaz Kabay, Sibel ; Cetiner, Mustafa ; Mestan, Emine ; Sevim, Mehmet ; Ayas, Selahattin ; Ozden, Hilmi ; Ozisik Karaman, Handan</creator><creatorcontrib>Kabay, Sahin ; Canbaz Kabay, Sibel ; Cetiner, Mustafa ; Mestan, Emine ; Sevim, Mehmet ; Ayas, Selahattin ; Ozden, Hilmi ; Ozisik Karaman, Handan</creatorcontrib><description>Objectıve To investigate the effect of percutaneous posterior tibial nerve stimulation (PTNS) treatment after 12 weeks on urodynamic and clinical findings in patients with Parkinson's disease (PD) with neurogenic detrusor overactivity. Methods A total of 47 patients with PD with neurogenic detrusor overactivity were enrolled in the study. Urodynamic studies before and after 12-week PTNS treatment were performed. International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), Overactive Bladder Questionnaire (OAB-V8), and Overactive Bladder Questionnaire Short Form (OAB-q SF) have been assessed before and after PTNS treatment. Results The mean first involuntary detrusor contraction volume ( 1st IDCV) on standard cystometry was 133.2 ± 48.1 (24-265) mL, whereas it was 237.3 ± 43.1 (145-390) mL after PTNS. The mean maximum cystometric capacity (MCC) on standard cystometry was 202.2 ± 36.5 (115-320) mL, whereas it was 292.1 ± 50.6 (195-395) mL after stimulation. The improvements in the first involuntary detrusor contraction volume and maximum cystometric capacity were statistically significant after stimulation. The mean Pdetmax at first involuntary detrusor contraction, maximal detrusor pressure at maximum cystometric capacity, PdetQmax, Qmax, and post-void residual volume were statistically significant after 12-week stimulation. Mean parametric improvements at 12-week PTNS treatment from baseline included daytime frequency decreased by 5.6 voids daily, urge incontinence decreased by 3.1 episodes daily, urgency episodes decreased by 6.3 episodes daily, nocturia decreased by 2.7 voids, and voided volume improved by a mean of 92.6 mL. The change from baseline on the ICIQ-SF, OABv8, and OAB-q at 12-week PTNS treatment demonstrated statistically significant improvements. Conclusion These results have demonstrated that PTNS improves the lower urinary tract symptoms and urodynamic parameters in patients with PD.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2015.09.026</identifier><identifier>PMID: 26436213</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Parkinson Disease - complications ; Surveys and Questionnaires ; Tibial Nerve ; Time Factors ; Transcutaneous Electric Nerve Stimulation - methods ; Treatment Outcome ; Urinary Bladder - physiopathology ; Urinary Bladder, Neurogenic - complications ; Urinary Bladder, Neurogenic - physiopathology ; Urinary Bladder, Neurogenic - therapy ; Urinary Bladder, Overactive - complications ; Urinary Bladder, Overactive - physiopathology ; Urinary Bladder, Overactive - therapy ; Urodynamics - physiology ; Urology</subject><ispartof>Urology (Ridgewood, N.J.), 2016-01, Vol.87, p.76-81</ispartof><rights>Elsevier Inc.</rights><rights>2015 Elsevier Inc.</rights><rights>Copyright © 2015 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-f929ffdc5ffce07177a554f837140675ab27719f354bf91211751800d0efa5ce3</citedby><cites>FETCH-LOGICAL-c420t-f929ffdc5ffce07177a554f837140675ab27719f354bf91211751800d0efa5ce3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0090429515009279$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26436213$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kabay, Sahin</creatorcontrib><creatorcontrib>Canbaz Kabay, Sibel</creatorcontrib><creatorcontrib>Cetiner, Mustafa</creatorcontrib><creatorcontrib>Mestan, Emine</creatorcontrib><creatorcontrib>Sevim, Mehmet</creatorcontrib><creatorcontrib>Ayas, Selahattin</creatorcontrib><creatorcontrib>Ozden, Hilmi</creatorcontrib><creatorcontrib>Ozisik Karaman, Handan</creatorcontrib><title>The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>Objectıve To investigate the effect of percutaneous posterior tibial nerve stimulation (PTNS) treatment after 12 weeks on urodynamic and clinical findings in patients with Parkinson's disease (PD) with neurogenic detrusor overactivity. Methods A total of 47 patients with PD with neurogenic detrusor overactivity were enrolled in the study. Urodynamic studies before and after 12-week PTNS treatment were performed. International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), Overactive Bladder Questionnaire (OAB-V8), and Overactive Bladder Questionnaire Short Form (OAB-q SF) have been assessed before and after PTNS treatment. Results The mean first involuntary detrusor contraction volume ( 1st IDCV) on standard cystometry was 133.2 ± 48.1 (24-265) mL, whereas it was 237.3 ± 43.1 (145-390) mL after PTNS. The mean maximum cystometric capacity (MCC) on standard cystometry was 202.2 ± 36.5 (115-320) mL, whereas it was 292.1 ± 50.6 (195-395) mL after stimulation. The improvements in the first involuntary detrusor contraction volume and maximum cystometric capacity were statistically significant after stimulation. The mean Pdetmax at first involuntary detrusor contraction, maximal detrusor pressure at maximum cystometric capacity, PdetQmax, Qmax, and post-void residual volume were statistically significant after 12-week stimulation. Mean parametric improvements at 12-week PTNS treatment from baseline included daytime frequency decreased by 5.6 voids daily, urge incontinence decreased by 3.1 episodes daily, urgency episodes decreased by 6.3 episodes daily, nocturia decreased by 2.7 voids, and voided volume improved by a mean of 92.6 mL. The change from baseline on the ICIQ-SF, OABv8, and OAB-q at 12-week PTNS treatment demonstrated statistically significant improvements. Conclusion These results have demonstrated that PTNS improves the lower urinary tract symptoms and urodynamic parameters in patients with PD.</description><subject>Adult</subject><subject>Aged</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Parkinson Disease - complications</subject><subject>Surveys and Questionnaires</subject><subject>Tibial Nerve</subject><subject>Time Factors</subject><subject>Transcutaneous Electric Nerve Stimulation - methods</subject><subject>Treatment Outcome</subject><subject>Urinary Bladder - physiopathology</subject><subject>Urinary Bladder, Neurogenic - complications</subject><subject>Urinary Bladder, Neurogenic - physiopathology</subject><subject>Urinary Bladder, Neurogenic - therapy</subject><subject>Urinary Bladder, Overactive - complications</subject><subject>Urinary Bladder, Overactive - physiopathology</subject><subject>Urinary Bladder, Overactive - therapy</subject><subject>Urodynamics - physiology</subject><subject>Urology</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUs1uEzEQthCIhsAjgHyDSxbbu17HF1CV8idVbURTcbQc77h1umsX2xtpn4ZXxVECBy5IlmxL38_MfIPQa0oqSmj7fleNMfThbqoYobwisiKsfYJmlDOxkFLyp2hGiCSLhkl-hl6ktCOEtG0rnqMz1jZ1y2g9Q78294BXvfPO6B5r3-HbGLrJ68EZ_B3S2OeEg8VriGbM2kMYE16HlCG6EPHGbV3hXUHcA77Jbhh7nV3wuJwrKBXeQVHGF5DjmAr-eg9Rm-z2Lk_YebwuaPDF4ofL9-UXH5xPwb9N-MIl0AleomdW9wlene45uv38abP6uri8_vJtdX65MA0jeWElk9Z2hltrgAgqhOa8scta0Ia0gustE4JKW_NmayVllApOl4R0BKzmBuo5enfUfYzh5wgpq8ElA31_bFlR0bK6WbIytDniR6iJIaUIVj1GN-g4KUrUIRu1U6ds1CEbRaQq2RTem5PFuB2g-8v6E0YBfDwCoDS6dxBVMmU6BjoXwWTVBfdfiw__KJhTtA8wQdqFMfoyRUVVYoqom8OCHPaD8vJiQta_AYbLuyU</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Kabay, Sahin</creator><creator>Canbaz Kabay, Sibel</creator><creator>Cetiner, Mustafa</creator><creator>Mestan, Emine</creator><creator>Sevim, Mehmet</creator><creator>Ayas, Selahattin</creator><creator>Ozden, Hilmi</creator><creator>Ozisik Karaman, Handan</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20160101</creationdate><title>The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease</title><author>Kabay, Sahin ; Canbaz Kabay, Sibel ; Cetiner, Mustafa ; Mestan, Emine ; Sevim, Mehmet ; Ayas, Selahattin ; Ozden, Hilmi ; Ozisik Karaman, Handan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-f929ffdc5ffce07177a554f837140675ab27719f354bf91211751800d0efa5ce3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Parkinson Disease - complications</topic><topic>Surveys and Questionnaires</topic><topic>Tibial Nerve</topic><topic>Time Factors</topic><topic>Transcutaneous Electric Nerve Stimulation - methods</topic><topic>Treatment Outcome</topic><topic>Urinary Bladder - physiopathology</topic><topic>Urinary Bladder, Neurogenic - complications</topic><topic>Urinary Bladder, Neurogenic - physiopathology</topic><topic>Urinary Bladder, Neurogenic - therapy</topic><topic>Urinary Bladder, Overactive - complications</topic><topic>Urinary Bladder, Overactive - physiopathology</topic><topic>Urinary Bladder, Overactive - therapy</topic><topic>Urodynamics - physiology</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kabay, Sahin</creatorcontrib><creatorcontrib>Canbaz Kabay, Sibel</creatorcontrib><creatorcontrib>Cetiner, Mustafa</creatorcontrib><creatorcontrib>Mestan, Emine</creatorcontrib><creatorcontrib>Sevim, Mehmet</creatorcontrib><creatorcontrib>Ayas, Selahattin</creatorcontrib><creatorcontrib>Ozden, Hilmi</creatorcontrib><creatorcontrib>Ozisik Karaman, Handan</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kabay, Sahin</au><au>Canbaz Kabay, Sibel</au><au>Cetiner, Mustafa</au><au>Mestan, Emine</au><au>Sevim, Mehmet</au><au>Ayas, Selahattin</au><au>Ozden, Hilmi</au><au>Ozisik Karaman, Handan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>87</volume><spage>76</spage><epage>81</epage><pages>76-81</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><abstract>Objectıve To investigate the effect of percutaneous posterior tibial nerve stimulation (PTNS) treatment after 12 weeks on urodynamic and clinical findings in patients with Parkinson's disease (PD) with neurogenic detrusor overactivity. Methods A total of 47 patients with PD with neurogenic detrusor overactivity were enrolled in the study. Urodynamic studies before and after 12-week PTNS treatment were performed. International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), Overactive Bladder Questionnaire (OAB-V8), and Overactive Bladder Questionnaire Short Form (OAB-q SF) have been assessed before and after PTNS treatment. Results The mean first involuntary detrusor contraction volume ( 1st IDCV) on standard cystometry was 133.2 ± 48.1 (24-265) mL, whereas it was 237.3 ± 43.1 (145-390) mL after PTNS. The mean maximum cystometric capacity (MCC) on standard cystometry was 202.2 ± 36.5 (115-320) mL, whereas it was 292.1 ± 50.6 (195-395) mL after stimulation. The improvements in the first involuntary detrusor contraction volume and maximum cystometric capacity were statistically significant after stimulation. The mean Pdetmax at first involuntary detrusor contraction, maximal detrusor pressure at maximum cystometric capacity, PdetQmax, Qmax, and post-void residual volume were statistically significant after 12-week stimulation. Mean parametric improvements at 12-week PTNS treatment from baseline included daytime frequency decreased by 5.6 voids daily, urge incontinence decreased by 3.1 episodes daily, urgency episodes decreased by 6.3 episodes daily, nocturia decreased by 2.7 voids, and voided volume improved by a mean of 92.6 mL. The change from baseline on the ICIQ-SF, OABv8, and OAB-q at 12-week PTNS treatment demonstrated statistically significant improvements. Conclusion These results have demonstrated that PTNS improves the lower urinary tract symptoms and urodynamic parameters in patients with PD.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26436213</pmid><doi>10.1016/j.urology.2015.09.026</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-4295
ispartof Urology (Ridgewood, N.J.), 2016-01, Vol.87, p.76-81
issn 0090-4295
1527-9995
language eng
recordid cdi_proquest_miscellaneous_1762348221
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Adult
Aged
Female
Follow-Up Studies
Humans
Male
Middle Aged
Parkinson Disease - complications
Surveys and Questionnaires
Tibial Nerve
Time Factors
Transcutaneous Electric Nerve Stimulation - methods
Treatment Outcome
Urinary Bladder - physiopathology
Urinary Bladder, Neurogenic - complications
Urinary Bladder, Neurogenic - physiopathology
Urinary Bladder, Neurogenic - therapy
Urinary Bladder, Overactive - complications
Urinary Bladder, Overactive - physiopathology
Urinary Bladder, Overactive - therapy
Urodynamics - physiology
Urology
title The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T18%3A19%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Clinical%20and%20Urodynamic%20Results%20of%20Percutaneous%20Posterior%20Tibial%20Nerve%20Stimulation%20on%20Neurogenic%20Detrusor%20Overactivity%20in%20Patients%20With%20Parkinson's%20Disease&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Kabay,%20Sahin&rft.date=2016-01-01&rft.volume=87&rft.spage=76&rft.epage=81&rft.pages=76-81&rft.issn=0090-4295&rft.eissn=1527-9995&rft_id=info:doi/10.1016/j.urology.2015.09.026&rft_dat=%3Cproquest_cross%3E1762348221%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1762348221&rft_id=info:pmid/26436213&rft_els_id=1_s2_0_S0090429515009279&rfr_iscdi=true